inappropriate ADH syndrome: A syndrome characterized by abnormal secretion of antidiuretic hormone in conjunction with neoplastic growth occurring anywhere in the body.
Syndrome of inappropriate secretion of antidiuretic hormone
DOID EFO Endpoint Browser PheWeb
E4_ANTIDIU
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
176 |
4. Check minimum number of eventsNone |
176 |
5. Include endpointsNone |
176 |
6. Filter based on genotype QC (FinnGen only) |
176 |
Control definitions (FinnGen only)
- Control exclude
- E4_ENDOGLAND
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E22
- Name in latin
- Syndroma secretionis impropriae hormonis antidiuretici
Similar endpoints
↥List of similar endpoints to
Syndrome of inappropriate secretion of antidiuretic hormone
based on the number of shared cases.
Similar with more cases:
- Hyperfunction of pituitary gland
- Exclusions for E4_PCOS_BROAD
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1631 | 971 | 648 |
| Only index persons | 1405 | 854 | 551 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 71.56 | 74.37 | 67.48 |
| Only index persons | 72.04 | 74.92 | 67.57 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 176 | 93 | 83 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | 69.29 | 69.51 | 69.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 157
- Matched controls
- 1570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E22.2
ICD-10 Finland
Syndrome of inappropriate secretion of antidiuretic hormone
+∞
210.6
151
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
101.6
101.1
108
33
H02AB09
ATC
hydrocortisone; systemic
23.7
13.7
19
9
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
9.3
10.7
22
27
N03AX14
ATC
levetiracetam; systemic
14.7
9.9
16
12
G40.9
ICD-10 Finland
Epilepsy, unspecified
13.5
9.6
16
13
AA1AD
NOMESCO Finland
CT of head and brain
3.1
9.4
64
283
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
25.8
9.0
12
5
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
6.5
9.0
23
40
S06.3
ICD-10 Finland
Focal brain injury
29.3
8.6
11
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.3
8.5
50
197
E22.1
ICD-10 Finland
Hyperprolactinaemia
+∞
8.4
8
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
18.4
8.2
12
7
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
23.5
8.1
11
5
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
12.7
7.7
13
11
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
83.8
7.5
8
*
N05BA04
ATC
oxazepam; oral
2.8
7.3
56
258
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.3
7.1
38
137
R11
ICD-10 Finland
Nausea and vomiting
4.3
7.1
26
69
N03AG01
ATC
valproic acid; systemic, rectal
6.2
7.0
18
32
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
7.0
37
132
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
6.9
29
88
S02.11
ICD-10 Finland
Fracture of base of skull, open
41.9
6.8
8
*
N06AX11
ATC
mirtazapine; oral
2.6
6.8
65
339
N05CF01
ATC
zopiclone; oral
2.5
6.6
68
369
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.5
6.6
66
351
A06AD11
ATC
lactulose; oral
3.1
6.4
38
147
2536X
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other disorders of neurohypophysis
+∞
6.3
6
*
R53
ICD-10 Finland
Malaise and fatigue
2.6
6.1
48
224
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.6
6.0
27
86
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3036481) Cortisol [Moles/volume] in Serum or Plasma
105
127
19.02
90.93
3.4
1.7
nmol/l
412.5
387.3
0.45
94
112
(3026782) Osmolality of Urine
108
295
7.89
42.59
4.8
3.1
mosm/kgh2o
466.4
557.6
4.67
95
253
(3035637) Corticotropin [Mass/volume] in Plasma
26
16
18.89
31.23
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
85
367
3.55
15.30
2.7
2.0
mg/l
2.8
3.2
1.19
69
314
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
124
725
3.40
12.80
9.0
6.4
mmol/l
1.2
1.2
0.45
95
606
(1616796) Gas panel - Central venous blood
19
29
7.22
12.18
2.8
2.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
102
560
2.95
11.24
3.0
2.5
ug/l
122.7
123.2
0.01
84
504
(3023368) Bacteria identified in Blood by Culture
85
431
2.88
10.74
5.2
4.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
19
7.92
9.85
3.7
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
87
468
2.70
9.53
5.7
3.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
83
448
2.61
8.88
5.5
4.1
ph
7.4
7.4
0.22
29
77
(3013290) Carbon dioxide [Partial pressure] in Blood
16
30
5.77
8.37
3.9
3.1
kpa
4.6
5.0
1.46
16
30
(3027315) Oxygen [Partial pressure] in Blood
16
30
5.77
8.37
3.9
3.1
kpa
8.9
8.2
1.12
16
30
(3006504) Eosinophils/100 leukocytes in Blood
102
621
2.53
8.30
7.2
5.7
%
2.4
2.6
0.48
94
571
(3019069) Monocytes/100 leukocytes in Blood
102
624
2.51
8.17
7.3
6.1
%
9.3
8.6
1.05
94
578
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
108
681
2.52
8.06
9.1
5.6
mmol/l
1.2
1.2
0.29
98
606
(3002030) Lymphocytes/100 leukocytes in Blood
102
633
2.45
7.79
7.6
6.0
%
23.2
27.0
2.99
95
578
(3013650) Neutrophils [#/volume] in Blood by Automated count
120
804
2.55
7.72
11.0
9.1
e9/l
5.0
4.2
1.63
107
706
(3022096) Basophils/100 leukocytes in Blood
98
601
2.42
7.64
7.5
5.6
%
0.6
0.6
0.01
90
554
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
11
15
7.76
7.64
1.8
1.8
ug/l
28.3
18.3
0.34
11
15
(3013115) Eosinophils [#/volume] in Blood
107
697
2.37
7.08
7.6
5.6
e9/l
0.2
0.2
0.76
97
617
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
25
78
3.57
7.01
7.6
6.3
mmol/l
24.0
25.0
0.62
25
78
(3006315) Basophils [#/volume] in Blood
104
674
2.33
6.90
7.6
5.5
e9/l
0.0
0.0
0.02
94
587
(3024561) Albumin [Mass/volume] in Serum or Plasma
100
638
2.31
6.88
4.2
4.5
g/l
33.4
35.3
2.85
91
593
(3019198) Lymphocytes [#/volume] in Blood
105
684
2.33
6.87
7.8
5.6
e9/l
1.6
2.0
1.42
94
611
(3001604) Monocytes [#/volume] in Blood
103
669
2.30
6.74
7.7
5.5
e9/l
0.6
0.6
1.08
94
582
(40760888) Immunoglobulin light chains.free panel - Serum
15
33
4.88
6.59
2.4
7.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
98
629
2.26
6.53
7.0
5.6
%
60.9
57.9
1.56
91
577
(3012544) pH of Venous blood
36
147
2.82
6.46
4.9
3.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
22
5.78
6.38
1.1
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
15
34
4.73
6.37
1.9
2.1
%
15.8
15.1
—
6
17
(3044290) Cell count panel - Cerebral spinal fluid
11
19
6.11
6.19
1.7
1.6
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
19
6.11
6.19
1.8
1.5
%
92.3
89.2
1.30
11
19
(3028271) Lactate [Moles/volume] in Capillary blood
12
24
5.29
5.83
1.7
1.5
mmol/l
1.8
1.5
0.34
12
24
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
77
464
2.17
5.83
2.7
2.5
u/l
50.8
56.1
0.80
70
427
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
25
88
3.15
5.79
4.0
2.6
%
1.3
1.3
0.13
25
88
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
111
779
2.15
5.57
6.4
6.2
umol/l
10.8
10.9
0.03
103
728
(3030467) Casts [#/volume] in Urine by Automated count
70
413
2.15
5.53
6.0
3.4
e6/l
0.5
0.6
0.14
65
315
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
49
250
2.33
5.51
2.0
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
58
318
2.23
5.50
2.2
1.7
nmol/l
1644.1
1218.2
1.71
34
229
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
84
534
2.10
5.44
6.4
3.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
175
2.49
5.34
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
175
2.49
5.34
2.0
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
19
5.52
5.10
4.7
3.6
e9/l
5.6
4.7
—
10
19
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
9
10.46
5.08
1.4
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
77
487
2.03
4.94
3.2
3.2
mmol/l
2.3
2.4
0.47
67
423
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
20
5.24
4.84
6.2
4.7
%
69.0
56.5
—
10
20
(3002582) Erythrocytes [#/volume] in Urine
73
458
2.01
4.75
6.2
3.5
e6/l
40.2
219.4
0.69
68
358
(3003396) Base excess in Arterial blood by calculation
40
199
2.31
4.71
7.0
5.9
mmol/l
1.0
1.5
0.44
27
156
(3027273) Bicarbonate [Moles/volume] in Venous blood
22
82
2.92
4.62
4.9
3.0
mmol/l
25.4
25.0
0.25
22
82
(3032080) INR in Blood by Coagulation assay
92
631
1.96
4.60
12.3
9.2
inr
1.3
1.3
0.03
37
171
(3008037) Lactate [Moles/volume] in Venous blood
14
39
3.81
4.59
4.5
3.4
mmol/l
1.5
1.5
0.05
14
39
(3038515) Glucose [Moles/volume] in Venous blood
14
39
3.81
4.59
4.5
3.3
mmol/l
8.0
8.0
0.01
14
39
(36304419) Bacteria [Presence] in Urine
65
396
2.02
4.56
6.2
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
78
507
1.97
4.55
3.2
3.3
ng/l
1331.4
1628.2
0.25
65
429
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
39
195
2.28
4.53
7.1
5.9
kpa
4.8
5.1
0.67
34
185
(3027801) Oxygen [Partial pressure] in Arterial blood
39
195
2.28
4.53
7.1
5.9
kpa
12.3
11.6
0.36
34
185
(3037467) Urinalysis macro (dipstick) panel - Urine
128
991
2.07
4.43
7.4
4.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
24
97
2.71
4.35
6.3
4.2
%
0.6
0.5
—
8
30
(3021440) Promyelocytes/100 leukocytes in Blood
25
104
2.64
4.29
6.9
4.5
%
0.1
0.2
—
10
39
(3016502) Oxygen saturation in Arterial blood
35
172
2.29
4.22
7.7
6.3
%
94.7
95.4
0.21
30
164
(42870588) Differential panel, method unspecified - Blood
69
439
1.94
4.22
6.4
5.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
137
1098
2.12
4.17
9.5
7.5
u/l
81.1
77.7
0.40
131
1009
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
34
166
2.30
4.16
3.3
5.6
u/l
238.5
239.8
0.02
28
154
(3027945) Reticulocytes/100 erythrocytes in Blood
36
182
2.23
4.06
2.7
3.6
%
1.9
1.8
0.22
27
161
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
89
622
1.87
4.04
5.7
4.2
ng/l
47.8
48.5
0.01
81
474
(40761536) Microorganisms panel - Urine sediment
25
109
2.51
3.90
7.6
3.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
128
1013
1.97
3.88
6.5
3.9
pmol/l
15.9
15.0
2.57
116
891
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
83
574
1.84
3.84
3.3
2.2
nmol/l
82.9
79.3
0.49
74
488
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
39
3.52
3.84
1.5
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
30
3.84
3.70
1.4
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
58
363
1.89
3.64
1.7
1.6
nmol/l
21.8
21.1
0.13
49
295
(3017181) Myelocytes/100 leukocytes in Blood
25
113
2.41
3.62
7.2
4.4
%
1.3
0.8
—
10
44
(46235355) HIV 1 and 2 tests - Meaningful Use set
32
162
2.19
3.58
1.5
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
41
3.34
3.57
1.3
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
13
6.39
3.54
1.4
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
77
533
1.79
3.47
6.7
4.0
e6/l
186.0
78.8
0.50
68
385
(3004588) Protein electrophoresis panel - Serum or Plasma
24
109
2.39
3.44
2.5
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
78
544
1.78
3.41
8.0
4.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
31
158
2.17
3.41
6.6
3.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
27
3.87
3.40
1.3
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
27
3.87
3.40
1.3
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
32
3.60
3.39
1.2
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
109
840
1.78
3.36
3.5
3.3
u/l
55.0
50.9
0.14
101
775
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
38
3.32
3.28
1.3
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
92
2.46
3.25
5.0
3.9
mmol/l
2.2
1.7
0.20
16
71
(3023520) Reticulocytes [#/volume] in Blood
26
126
2.25
3.22
2.2
4.0
e9/l
75.8
70.9
0.28
17
105
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
20
4.68
3.16
1.3
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
22
100
2.37
3.15
7.1
4.5
%
0.0
0.2
—
8
34
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
56
2.83
3.15
3.3
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
80
572
1.73
3.15
18.4
9.9
e9/l
0.0
0.0
0.39
70
469
(3041096) Erythrocytes [Presence] in Urine by Automated
57
370
1.80
3.13
7.6
3.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
26
128
2.21
3.11
10.0
7.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
29
3.60
3.09
4.8
2.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
10
29
3.60
3.09
4.8
2.7
mmol/l
4.3
4.1
—
10
29
(3035285) Chloride [Moles/volume] in Venous blood
10
29
3.60
3.09
4.8
2.7
mmol/l
94.3
105.7
—
10
29
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
8
7.71
3.08
1.2
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
76
2.52
3.00
1.6
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
93
701
1.69
2.96
7.2
4.3
estimate
0.0
0.0
0.00
30
111
(3008152) Bicarbonate [Moles/volume] in Arterial blood
24
117
2.22
2.94
5.8
5.9
mmol/l
24.4
24.3
0.01
19
109
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
9
22
4.25
2.92
3.9
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
83
609
1.69
2.91
2.5
2.0
pmol/l
97.7
94.4
0.23
37
303
(3016018) Differential panel - Cerebral spinal fluid
6
9
6.85
2.89
1.5
2.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
12
43
2.92
2.70
2.7
2.3
mmol/l
24.7
24.7
0.01
12
33
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
15
61
2.59
2.70
1.3
1.3
—
57.6
—
0
5
(3013707) Erythrocyte sedimentation rate by Westergren method
123
1013
1.71
2.69
6.2
4.1
mm/h
16.1
13.4
1.00
115
909
(3021601) Nitrite [Presence] in Urine by Test strip
91
695
1.64
2.66
9.2
5.7
estimate
0.0
0.0
0.00
30
116
(40760892) CBC W Ordered Manual Differential panel - Blood
46
293
1.77
2.65
9.6
5.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
57
386
1.71
2.65
8.3
4.5
estimate
0.0
0.0
0.00
30
112
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
25
3.74
2.61
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
90
690
1.62
2.56
7.3
4.2
estimate
0.0
0.0
0.00
30
118
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.94
2.49
1.4
1.8
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
12
5.13
2.42
1.2
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
12
5.13
2.42
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
35
2.97
2.34
1.9
2.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
121
2.04
2.34
1.2
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
28
159
1.90
2.31
1.9
3.0
umol/l
6.2
8.6
0.53
22
129
(3021901) Oxygen saturation in Capillary blood
9
29
3.21
2.26
2.6
2.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
9
5.68
2.23
2.0
2.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
89
2.14
2.14
1.4
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
37
2.81
2.14
1.2
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
10
5.11
2.08
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
10
5.11
2.08
3.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
44
295
1.66
2.08
2.2
1.9
pmol/l
434.5
459.5
0.25
33
241
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
20
3.60
2.07
3.6
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
20
3.60
2.07
1.1
3.1
pg
31.3
32.2
—
7
20
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
44
296
1.65
2.05
3.4
3.0
mmol/l
2.5
2.5
0.13
39
259
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
70
2.25
2.05
2.8
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
48
333
1.61
1.98
1.3
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
27
3.05
1.96
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
33
2.82
1.96
1.1
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
11
4.64
1.95
1.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
11
4.64
1.95
2.0
2.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
16
3.84
1.95
2.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
16
3.84
1.95
2.2
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
12
52
2.40
1.92
1.4
1.3
u/ml
78.0
162.3
1.05
12
43
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
79
2.13
1.92
1.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
123
1.90
1.90
4.5
3.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
22
3.27
1.90
1.4
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
12
4.25
1.83
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
24
140
1.83
1.83
1.4
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
90
727
1.49
1.83
2.8
2.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
81
641
1.49
1.82
5.0
4.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
110
1.92
1.82
1.6
2.5
g/l
0.2
0.2
0.57
15
103
(3015736) pH of Urine
71
548
1.50
1.80
5.9
4.1
—
—
—
0
0
(4062490)
5
13
3.92
1.72
1.8
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
25
2.87
1.67
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
12
56
2.23
1.65
2.1
1.2
—
—
—
0
0
(3020891) Body temperature
14
70
2.09
1.64
6.1
3.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
14
3.64
1.62
1.6
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
20
3.07
1.59
1.5
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
33
2.49
1.56
1.7
1.2
g/l
0.2
0.2
—
8
33
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
17
94
1.89
1.53
3.0
3.4
ng/l
69.3
82.7
—
10
82
(3044941) Cell count panel - Synovial fluid
5
15
3.40
1.53
1.2
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
150
1374
1.62
1.46
30.4
16.0
mg/l
26.1
25.3
0.12
137
1111
(3007853) Bacteria identified in Skin by Aerobe culture
27
175
1.64
1.45
1.8
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
81
1.93
1.45
6.5
4.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
16
3.18
1.45
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
16
3.18
1.45
1.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
22
2.79
1.44
1.2
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
49
365
1.47
1.44
7.4
7.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
24
152
1.67
1.41
1.5
1.3
titre
365.7
481.1
—
7
35
(4035726)
22
136
1.71
1.41
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
37
262
1.52
1.38
5.0
2.9
e6/l
0.7
1.1
0.79
32
159
(40768797) Stomach Pathology biopsy report
29
194
1.59
1.38
1.1
1.2
—
—
—
0
0
(3013512) EKG study
57
441
1.43
1.37
5.1
4.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
17
3.00
1.37
2.4
2.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
114
1.75
1.35
2.3
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
24
2.55
1.31
2.0
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
48
2.15
1.30
1.6
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
35
2.35
1.28
2.1
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
35
2.35
1.28
1.9
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
35
2.35
1.28
1.9
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
137
1247
1.45
1.21
7.4
4.7
mu/l
2.0
2.0
0.00
124
1099
(3019225) pH of Specimen
21
134
1.64
1.21
3.9
4.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
26
2.35
1.19
1.2
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
154
1438
1.57
1.16
41.3
18.9
mmol/l
4.1
4.0
3.30
149
1391
(40768806) Pleura Pathology biopsy report
5
20
2.54
1.16
1.2
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
74
1.82
1.10
5.9
3.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
45
2.05
1.06
2.9
3.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
25
174
1.51
1.02
2.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
76
1.77
1.02
1.4
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
244
1.43
1.01
5.6
3.0
e6/l
0.8
2.4
1.52
28
144
(1761482) Bacteria [#/volume] in Urine by Culture
9
49
1.88
1.00
9.2
6.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
23
2.21
0.98
1.0
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
35
263
1.41
0.98
1.4
1.5
g/l
4.8
2.7
0.42
19
151
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
50
1.84
0.98
1.2
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
17
109
1.62
0.98
4.2
3.4
ml/min/173m2
59.6
60.5
—
7
48
(40768800) Prostate Pathology biopsy report
0
32
0.00
0.96
0.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
12
71
1.74
0.91
3.8
2.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
180
1.45
0.88
16.6
8.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
29
215
1.42
0.88
1.8
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
30
2.03
0.88
1.2
1.2
—
—
—
0
0
(4034850)
8
44
1.86
0.87
18.4
11.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
67
567
1.29
0.87
2.3
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
324
1.35
0.86
1.5
1.7
mg/l
1.7
1.5
0.16
33
255
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
65
1.74
0.84
1.6
3.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
122
0.56
0.81
1.6
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
55
461
1.28
0.76
3.0
2.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
25
2.03
0.73
1.0
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
7
41
1.74
0.71
2.0
2.0
g/l
126.0
123.0
—
7
28
(1002224) Polysomnography panel
7
41
1.74
0.71
1.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
41
334
1.30
0.70
3.1
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
86
1.55
0.68
1.8
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
46
383
1.27
0.67
2.5
3.1
umol/l
300.0
7964.9
2.21
31
313
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
28
1.81
0.66
2.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
18
129
1.44
0.66
2.3
2.4
ng/l
254.8
207.6
0.17
18
111
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
22
288
0.73
0.66
2.4
2.9
ug/l
0.6
0.7
0.85
17
190
(3009508) Creatinine [Moles/volume] in Urine
51
431
1.26
0.65
2.9
3.0
mmol/l
5.5
7.2
3.55
42
347
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
49
1.66
0.63
1.3
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
30
1.69
0.62
1.4
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
123
1306
0.81
0.60
4.5
4.6
mmol/l
1.5
1.5
1.25
110
1176
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
35
285
1.28
0.60
7.5
3.6
ng/l
18.0
189.4
1.59
30
235
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
276
1.29
0.60
1.3
1.2
u/ml
1.4
0.8
—
7
66
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
35
1.74
0.58
1.2
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
411
0.79
0.58
3.5
4.5
%
20.2
21.6
0.30
20
204
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
36
1.69
0.57
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
126
1183
1.23
0.57
28.6
17.3
%
33.9
39.1
3.34
77
797
(3003327) Ova and parasites identified in Stool by Light microscopy
6
38
1.60
0.55
1.2
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
126
1.39
0.54
5.3
3.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
52
450
1.22
0.54
3.8
3.8
mg/mmol
3.6
7.8
1.60
33
285
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
150
1438
1.29
0.54
15.0
10.9
u/l
26.0
24.4
0.23
145
1369
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
338
1.24
0.51
5.7
4.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
65
1.41
0.51
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
148
1419
1.27
0.51
28.1
14.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
49
424
1.22
0.51
2.9
3.0
mg/l
21.0
193.8
0.60
32
272
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
129
1349
0.84
0.44
5.1
5.3
mmol/l
2.4
2.6
2.17
116
1219
(4094501)
5
32
1.58
0.42
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
32
374
0.82
0.41
1.6
1.7
mmol/l
1.2
1.3
0.28
27
309
(40768795) Lymph node Pathology biopsy report
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
19
152
1.28
0.39
3.1
2.6
ug/l
5.1
5.1
0.00
14
135
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
68
1.34
0.38
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
69
1.32
0.38
1.2
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
187
0.78
0.34
3.7
4.7
%
43.0
31.7
—
10
120
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
121
1262
0.87
0.34
4.0
4.2
mmol/l
1.1
1.3
2.40
108
1132
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
126
1310
0.87
0.33
4.3
4.7
mmol/l
4.3
4.5
2.23
113
1191
(3007461) Platelets [#/volume] in Blood
154
1499
1.22
0.33
43.4
23.2
e9/l
264.4
244.6
3.15
149
1452
(3000492) Spirometry study
14
111
1.28
0.31
1.1
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
154
1501
1.21
0.31
43.4
23.2
e12/l
4.1
4.4
9.73
147
1446
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
54
1.31
0.31
1.3
1.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
154
1502
1.20
0.30
43.4
23.2
e9/l
7.0
6.9
0.31
147
1447
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
168
1.21
0.28
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
106
1.24
0.24
3.0
2.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
37
1.36
0.23
1.8
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
10
80
1.27
0.21
16.5
8.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
165
0.84
0.20
1.6
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
11
90
1.24
0.19
6.1
2.7
e9/l
4.2
4.2
—
6
64
(1761868) Lipid panel - Serum or Plasma
38
413
0.90
0.19
3.1
3.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
52
1.16
0.19
2.7
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
76
0.78
0.16
2.0
1.9
—
—
—
0
0
(4010399)
9
106
0.84
0.13
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
131
1285
1.08
0.12
32.1
15.2
ml/min/173m2
81.0
75.7
1.93
118
1034
(36660697) Celiac disease serology panel - Serum
11
96
1.16
0.10
1.3
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
18
164
1.11
0.10
1.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
49
508
0.95
0.07
4.5
5.1
ug/l
1.7
2.3
1.07
43
441
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
134
1323
1.05
0.07
5.6
5.0
mmol/l
6.2
6.1
0.17
119
1186
(3019150) Specific gravity of Urine by Refractometry
34
327
1.05
0.05
7.8
4.6
kg/l
1.0
1.0
—
7
43
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
21
203
1.04
0.01
1.3
1.3
iu/ml
18.6
31.8
—
10
66
(3022145) Colonoscopy Study observation
16
161
0.99
0.00
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
129
1289
1.00
0.00
7.1
6.3
mmol/mol
41.3
40.8
0.20
118
1188
(3044889) 12 lead EKG panel
100
1001
1.00
0.00
4.8
4.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.0
—
6.5
—
0
5
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
66.9
—
0
6
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
8.1
—
0
5
(44806420)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44813793)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
71
0.99
0.00
1.7
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
60
1.00
0.00
1.5
2.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
58
0.86
0.00
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
1.0
—
0
7
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_ANTIDIU and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ANTIDIU | 2.117 [1.65, 2.72] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.177 |
During the follow-up period (1.1.1998 — 31.12.2019), 348 out of 767 females with E4_ANTIDIU died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ANTIDIU | 3.366 [2.32, 4.88] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 270 out of 507 males with E4_ANTIDIU died.
Mortality risk
Mortality risk for people of age
years, who have E4_ANTIDIU.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.198% | 0.597% |
| 5 | 1.064% | 3.778% |
| 10 | 2.882% | 8.794% |
| 15 | 5.999% | 16.438% |
| 20 | 10.228% | 26.295% |
Relationships between endpoints
↥Index endpoint: E4_ANTIDIU – Syndrome of inappropriate secretion of antidiuretic hormone
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data